This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit
15 - 19 June 2026
JW Marriot, Berlin, GermanyAttend In-Person or 100% Digitally

Shelley Jambresic
Group Lead Science & Evaluation at Geistlich Pharma AG
Speaker, Advisor

Profile

Shelley Jambresic is a Group Lead Science & Evaluation at Geistlich Pharma, responsible for clinical evaluation and clinical data interpretation of class III medical devices of animal origin. She is experienced in planning and conducting pre- and post-market clinical trials with medical devices and had the lead for implementation of MDR requirements in clinical processes at Geistlich Pharma. By training, Shelley Jambresic is a microbiologist and science communicator with extensive experience in medical and science writing.

Agenda Sessions

  • Panel: Clinical and Performance Evidence Expectations: Are We Finally Aligned?

    16:15